Jentadueto

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Jentadueto (linagliptin/metformin hydrochloride): printed package leaflets of specific batches intended for Sweden and Finland contain Norwegian text without the latest safety update English (EN) (121.38 KB - PDF) First published: 20/08/2026 View

Key facts

Medicine name Jentadueto Active substance linagliptin metformin hydrochloride Therapeutic area (MeSH) Diabetes Mellitus, Type 2 DHPC type Quality defect Human ATC codes A10BD11 Dissemination date 20/08/2026

Related medicine information

Jentadueto